Preve raises $2M to mend the physiotherapy industry using AI

Preve, a physiotherapy platform that uses AI to personalise treatment plans, has raised $2 million in seed funding led by Carthona Capital.

Preve was founded by Adam Beaupeurt and physiotherapist Caelum Trott as a way to help people do the hardest, and most important, part of physio: sticking to the exercises.

“Physios want their patients to get better, but our research suggests that patients drop out of care 80% of the time,” Trott said.

“Physios are stuck using tools that haven’t evolved in years. So, Preve lets them do more with less, providing care that’s consistent, trackable, and actually works for the modern patient.”

There are around 45,000 physiotherapists registered with the Physiotherapy Board in Australia, a number that increased by 6% in 2023-24 – higher than our population is growing.

Beapeurt said Preve isn’t there to replace physiotherapists so much as enhance their practice and get better outcomes for patients.

“AI is only now reaching the point where it can genuinely help improve patient outcomes in physical therapy,” he said.

“By filling the gap between consultations, and coaching the patient towards positive outcomes, we’re amplifying the practitioner and their expertise.”

The $2 million funding round includes backing from Startmate, Archangel, Black Sheep Capital, and Eucalyptus co-founders Alexey Mitko and Charlie Gearside.

“Preve is solving a widespread but under-discussed problem,” said Carthona Capital partner Dean Dorrell.

“We invested because they’re unlocking better outcomes for clinicians, patients and the wider health system – and doing it with empathy, insight, and precision.”

Preve was part of Startmate’s Winter 2024 accelerator alongside Buster, Trava Health, and Tendl.